Commercially available CFTR kits which target the most common CF-causing mutations (CT, in Table 2) are routinely used providing quick and limited-cost result, but limitations of these tests in terms of sensitivity must be explained, so that the couple understands the notion of residual risk. The gene discussed is CFTR; the disease is cystic fibrosis.